TCL Archive NCI Director Says Research Budget Cuts Result in Untold “Missed Opportunities,” Provides List of Program Reductions. March 9, 2007
TCL Archive Congressional Appropriations Committee Leaders Blast White Plans To Slash NIH FY 1987 Budget February 20, 1987
TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
